Immunologic studies in American patients with Burkitt-like lymphoma.
D000917:Antibody Formation; D002051:Burkitt Lymphoma / Q000276:immunology*; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed; D007275:Injections, Intravenous; D008214:Lymphocytes; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D008297:Male; D010051:Ovarian Neoplasms / Q000473:pathology; D010587:Phagocytosis; D011379:Prognosis; D012882:Skin Tests; D014481:United States; D005719:gamma-Globulins
D005719:gamma-Globulins; D003520:Cyclophosphamide